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Background: β-thalassemia is primarily found in individuals of Mediterranean and Southeast Asian ancestry. With rapid growth in 
the Southeast Asian segments of the Korean population, the geographic distribution of hemoglobinopathies is expected to be-
come significantly different from what it is today. In this study, Hb fractions were measured in patients with hypochromic microcy-
tosis to detect thalassemia and Hb variants. To evaluate the feasibility of replacing cellulose acetate electrophoresis (CA) with capil-
lary electrophoresis (CE) in a clinical laboratory, both techniques were performed and the outcomes were compared. 
Methods: To evaluate hemoglobinopathies, complete blood cell counts (CBC), CA, and CE were carried out on samples from heal-
thy and microcytic hypochromic groups. The microcytic hypochromic group consisted of 103 patients whose mean corpuscular 
volume (MCV) was less than 75 fL and mean corpuscular hemoglobin (MCH) was less than 24 pg. Quantitative analysis of Hb frac-
tions was performed on 143 whole blood samples. 
Results: There was a good correlation for measurements of HbA (r=0.9370, P<0.0001), HbA2 (r=0.8973 P<0.0001), and HbF (r= 
0.8010, P=0.0304) between the two methods. In the microcytic hypochromic group, there were 29 cases (28.2%) with decreased 
HbA2, 2 cases (1.9%) with increased HbA2, 3 cases (2.9%) with increased HbF, and 2 cases (1.9%) with increased HbA2 and HbF.
Conclusions: CE is comparable to CA for reliable measurement of Hb fractions. It is suitable for screening of hemoglobinopathies 
in many clinical laboratories. 
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INTRODUCTION
Inherited disorders of Hb are classified into thalassemias 
and structural variants [1]. Thalassemia is characterized by 
defects in the synthesis of a globin chain, and the majority 
of thalassemias involve α- or β-globin chains [2, 3]. Struc-
tural variants, called hemoglobinopathies, are structural ab-
normalities of Hbs [4]. 
The β-thalassemia trait is associated with mild or no ane-
mia but with reduced mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH) values, and an ele-
vated HbA2 level [5]. β-thalassemia is uncommon in the 
Korean population; however, it must be considered in the 
differential diagnosis of hypochromic anemia [6]. 
HbA2 has been measured using cellulose acetate (alka-
line) or citrate agar (acid) electrophoresis, isoelectrofocus-
ing (IEF), microcolumn chromatography, and high-perfor-
mance liquid chromatography (HPLC) [7]. Electrophoresis 
is the main tool used for the identification and quantifica-
tion of variant Hbs. This provides a clear background, but it 
is not possible to differentiate between HbE and HbO, and 
between HbD and HbG [8]. Moreover, electrophoresis is 
time-consuming, labor-intensive, and inaccurate in the quan-
tification of low-concentration Hb variants or in the detec-
tion of fast Hb variants [8]. Although IEF has excellent res-
olution, it has the same disadvantages as other electropho-
retic methods [7, 8]. Column chromatography is satisfac-
tory for β carrier diagnosis; however, it is also laborious, in-
tensive, and time-consuming [7]. In addition, HbA2 increases Kim J-E, et al.  •  Capillary EP for Hemoglobinopathies
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slightly in the presence of unstable Hb [7]. 
HPLC is the method of choice for the initial screening of 
Hb variants and for quantification of Hb fractions. How-
ever, its use has not become widespread in clinical laborato-
ries since it requires special instrumentation and training, 
and the results appear in complex patterns [9]. Consequen-
tly, many clinical laboratories still use alkaline and acid gel 
electrophoresis to screen for hemoglobinopathies. Addi-
tionally, HPLC has some limitations, including falsely de-
creased HbA2 levels in patients with the HbD Punjab trait, 
falsely increased HbA2 levels in patients with HbS, and co-
elution of various Hbs, including HbE, Hb Osu Christian-
borg, HbG Coushatta, and Hb Lepore with HbA2 [10]. 
Capillary electrophoresis (CE) has been presented as an 
alternative tool capable of separating the normal Hbs (A, F, 
and A2), and detecting the major Hb variants by alkaline 
electrophoresis on silica capillaries [11]. It can achieve si-
multaneous analysis, fast separation, good resolution, high 
accuracy, and full automation. Furthermore, this method is 
better able to separate HbA2 from HbE, HbC, Hb Lepore, 
and HbS than the HPLC method [7]. As the use of CE ex-
pands for evaluation of thalassemia and hemoglobinopa-
thies, it may help reveal the characteristics and prevalence 
of thalassemia mutations in the Korean population that is 
different from those of high prevalence area.
In this study, Hb fractions were measured in patients with 
hypochromic microcytosis to detect thalassemia and Hb 
variants and CE was compared with cellulose acetate elec-
trophoresis (CA) to replace CA by CE in a clinical labora-
tory. To the best of our knowledge, this is the first compara-
tive study of CE and CA for the screening of hemoglobin-
opathies in Korea.
MATERIALS AND METHODS
1. Samples
Thalassemias and hemoglobinopathies were evaluated in 
143 adult blood samples collected in EDTA tubes. Among 
these, 51 came from male donors and 92 from female do-
nors. The median age was 47 yr (range, 20-89 yr). Forty sam-
ples were obtained from normal individuals during a regu-
lar health check-up. One hundred and three samples were 
obtained from patients with hypochromic microcytosis. 
The microcytic hypochromic group consisted of patients 
with an MCV of less than 75 fL and an MCH less than 24 
pg with or without anemia [7]. Patients having conditions 
such as acute and chronic inflammatory diseases, infections, 
thyroiditis, acute bleeding, or any type of malignancy that 
might affect ferritin or Hb levels were excluded. Complete 
blood cell counts (CBC), CE, and CA were performed on 
each sample. 
2. Hematologic studies
The CBCs were determined by an automated blood cell 
analyzer XE2100 (Sysmex, Kobe, Japan) within 3 hr after 
blood collection. Serum iron levels, total iron-binding ca-
pacities (TIBC), and serum ferritin levels were measured in 
each case. Serum iron levels and TIBC were measured us-
ing a Toshiba 200FR autoanalyzer (Toshiba Co., Tokyo, Ja-
pan). Serum ferritin levels were evaluated by an Architect 
system (Abbott Laboratories, Abbott Park, IL, USA).
3. Cellulose acetate electrophoresis
The Helena electrophoresis system (Helena Laboratories, 
Beaumont, TX, USA) was used to electrophorese hemoly-
sates on Titan III cellulose acetate plates at 350 V for 25 min 
in an alkaline buffer. The results were analyzed according to 
manufacturer’s guidelines. 
4. Capillary electrophoresis
The CE was performed using the Minicap system (Sebia, 
Norcross, France) according to the manufacturer’s instruc-
tions, running controls with every test as described previ-
ously [9]. The Minicap system uses the principle of CE in 
free solution. Charged molecules are separated by their elec-
trophoretic mobility in an alkaline buffer with a specific pH. 
Separation also occurs according to the electrolyte pH and 
electro-osmotic flow. This novel system has capillaries in 
parallel allowing multiple and simultaneous analysis. Elec-
tropherograms were expressed with divided zones from Z1 
to Z15 based on standardizing the location of HbA. 
5. Reference values of the two methods
Manufacturer’s reference values were used and the refer-
ence values were validated by analysis of samples from 40 
outpatients and inpatients exhibiting RBC, Hb, MCV, MCH, 
and MCHC (mean corpuscular hemoglobin concentration) 
within the reference ranges. 
6. Confirmation
To confirm β-thalassemia, molecular analysis of the β-glo-
bin gene was performed in one case. Sequencing was carried 
out in a reference laboratory. 
7. Statistical analysis 
Statistical calculations were performed with MedCalc 
11.3.0.0 (Med Calc Software Company, Mariake, Belgium). 
Student’s t-test was used to compare RBC parameters and 240     www.kjlm.org
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Hb fractions between the control and microcytic hypochro-
mic groups. Comparison of the methods was made with Stu-
dent’s t-test and linear regression. Values of P<0.05 were 
considered statistically significant. 
RESULTS
1. Separation of normal and variant hemoglobins by CE
Using CE, we ran the AFSC control (containing HbA, 
HbF, HbS, HbA2, and HbC) (Fig. 1A). Major hemoglobins, 
including A, F, S, and C and normal Hbs separated well. In 
the Minicap system, the pattern of fractions comes out from 
right to left in the following order: from HbA2 to HbA (Fig. 
1B). Glycated fractions were not separated from HbA on CE. 
2. Reference values
For CE, the expected values provided by the manufacturer 
are 96.8-97.8% for HbA, <0.5% for HbF, and 2.2-3.2% for 
HbA2. Thus, we validated the manufacturer’s recommenda-
tions and set our laboratory’s reference range to 96.8-97.8% 
for HbA, <1% for HbF, and 2.2-3.5% for HbA2.
For CA, we adjusted the normal ranges for adults to 96.8-
97.8% for HbA, <1% for HbF, and 1.9-3.5% for HbA2.
3.   CBC and Hb fractions in normal control and microcytic 
hypochromic group
In the microcytic hypochromic group, Hb, Hct, MCV, 
MCH, and MCHC showed significant differences compared 
with those of the control group (P<0.0001) (Table 1). There 
was no significant difference for Hb fraction quantification 
between the two groups (P>0.05) (Table 2). 
4. Comparison of the two methods 
There was a good correlation for measurements of HbA (r 
=0.9370, P<0.0001), HbA2 (r=0.8973, P<0.0001), and 
HbF (r=0.8010, P=0.0304) between the two methods (Fig. 
2). Both techniques showed similar levels for HbA (97.4± 
0.7% by CE; 97.4±1.1% by CA) and HbA2 (2.5±0.6% by 
CE; 2.5±0.7% by CA). The methods also showed compara-
ble results with respect to HbF levels (0.4±1.1% by CE; 0.5± 
2.7% by CA). No statistically significant difference was found 
Fig. 1. A representative pattern of Hb separation using CE for AFSC control (A) and normal HbA2 control (B).
Abbreviations: CE, capillary electrophoresis; CA, cellulose acetate electrophoresis.
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Table 1. Comparison of RBC parameters between the control group and the 
microcytic hypochromic group*
Control group  
(Mean±SD) N=40
Microcytic hypochromic group 
(Mean±SD) N=103
RBC (×10
6/µL) 4.51±0.34 4.51±0.75
HB (g/dL) 13.9±0.9 9.64±1.8
Hct (%) 40.7±2.4 31.8±5.1
MCV (fL) 90.3±4.4 70.6±3.8
MCH (pg) 30.9±1.6 21.4±1.8
MCHC (%) 34.4±1.6 30.3±1.5
*P<0.0001 except RBC.
Abbreviations: RBC, red blood cell; MCV, mean corpuscular volume; MCH, mean cor-
puscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
Table 2. Comparison of hemoglobin fractions between the control group and 
the microcytic hypochromic group*
Control group  
(Mean±SD) N=40
Microcytic hypochromic group 
(Mean±SD) N=103
HbA (%) 97.18±0.26 97.57±0.77
HbF (%) 0.47±0.16 1.11±1.04
HbA2 (%) 2.74±0.20 2.35±0.54
*P>0.05.Kim J-E, et al.  •  Capillary EP for Hemoglobinopathies
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HbA2, both methods achieved complete agreement in 2 cases 
(100%). The overall concordance of the 2 methods for Hb 
fractions was 89.5% (128/143) (Table 4). 
5. Cases showing abnormal Hb fractions 
The total incidence of abnormal Hb fractions was 1.4% as 
detected by both CE and CA. In the microcytic hypochro-
mic group, there were 29 cases with decreased HbA2, 2 cases 
with increased HbA2, 3 cases with increased HbF, and 2 cases 
with both increased HbA2 and HbF. With the exclusion of 
the iron deficiency anemia (IDA) patients, 2 patients (1.4%) 
were suspected to have thalassemia minor. One of these, with 
an HbA2 level of 6.3%, was confirmed by sequencing. One 
of the cases with increased HbF had IDA.
DISCUSSION
β-thalassemia is primarily found in individuals of Medi-
terranean, African, and Southeast Asian ancestry [1]. In 
Korea, approximately 20 cases with β-thalassemia have been 
reported since the first case report in 1988 [12, 13]. How-
ever, with rapid growth in the Southeast Asian segment of 
the Korean population, the geographic distribution of he-
moglobinopathies is expected to become significantly dif-
ferent from what it is today. In this study, CE and CA were 
used to measure Hb fractions from patients with hypochro-
mic microcytosis to compare their ability to detect thalasse-
mia and Hb variants. 
Diagnosis of β-thalassemia can be made by analysis of 
erythrocyte indices and morphology, and quantification of 
HbA2 using conventional methods, including HPLC, elec-
Table 3. Values of HbA, HbF, and HbA2 determined using CE and CA*
CE CA
HbA 97.4±0.7 97.4±1.1
HbF 0.4±1.1 0.5±2.7
HbA2 2.5±0.6 2.5±0.7
*P<0.05.
Abbreviations: CE, capillary electrophoresis; CA, cellulose acetate electrophoresis.
Table 4. Number of patients with abnormal Hb levels found by CE and CA (N= 
143)
CE CA
Decreased HbA2 29 (20.3%) 15 (10.5%)
Elevated HbA2 2 (1.4%) 2 (1.4%)
Elevated HbF 3 (2.1%) 2 (1.4%)
Abbreviations: CE, capillary electrophoresis; CA, cellulose acetate electrophoresis.
Fig. 2. The correlation in HbA (A), HbA2 (B), and HbF (C) measurement be-
tween the two methods.
Abbreviations: CE, capillary electrophoresis; CA, cellulose acetate electropho-
resis.
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for Hb quantification (P>0.05) (Table 3). 
Among the 143 specimens, 29 (20.3%) vs. 15 (10.5%) were 
found to have decreased HbA2, and 3 (2.1%) vs. 2 (1.4%) 
had increased HbF for CE vs. CA, respectively. For elevated 242     www.kjlm.org
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trophoresis, and microcolumn techniques [14]. Quantifica-
tion of HbA2 is challenging because its level is low and in-
creases only slightly in disease, and other Hb variants often 
interfere with its measurement [15]. CA is routinely used 
but is inaccurate. HPLC is the method of choice but is costly 
and not routinely available. Previous studies have shown 
that the recently introduced CE separates HbA2 well from 
HbE, HbC, and HbS, with very good CV levels suitable for 
screening [15]. This method has the advantages of high effi-
ciency (multiple samples can be run in parallel), high accu-
racy, and full automation. 
In this study, there was good correlation for measurements 
of HbA, HbF, and HbA2 between CE and CA. The percent-
age of agreement on Hb fractions between CE and CA was 
89.5%. CA did not identify some HbA2 decreases and HbF 
increases. This may indicate that CE is more sensitive than 
CA for detecting Hb fractions. Because only one-third of 
globin gene mutations causing Hb abnormalities change the 
charge of Hb and one-quarter of the residues of Hb are in-
ternally situated, CA detects only 25% of hemoglobin vari-
ants [16, 17]. Several studies have revealed poor precision 
for HbA2 quantification methods based on electrophoresis 
[8]. In addition, the prominent feature of the CE method is 
the ability to separate HbA2 completely from HbE [10, 18]. 
Tandem mass spectrometry has been able to measure HbA2 
in the presence of HbE. However, the present CE method 
provides this information in a simplified format [9].
CE patterns were easier to interpret than CA patterns. 
While the latter needs technical expertise, the former pro-
vides objective results and various settings available for in-
terpretation, recording, and archives. However, the presence 
of HbA is essential for CE to obtain appropriate zones for 
verifying the identity of the Hb. 
A practical method for routine Hb electrophoresis is cel-
lulose acetate at alkaline pH. It is rapid and reproducible 
and separates Hbs A, F, S, C, and A2. The use of citrate agar 
electrophoresis at acid pH permits further separation of 
several common variants that migrate together on cellulose 
acetate: S from D and G, and C from E and O [19]. Never-
theless, citrate agar electrophoresis is not widely used be-
cause it is slow and difficult to standardize [20]. The agar 
plates must be freshly made and electrophoretic mobilities 
are often inconstant owing to the relatively high electrical 
resistance of the citrate agar, leading to variable effects on 
the Hb [20].
Various cell counter-based formulae have been published 
to investigate microcytosis and to discriminate between thal-
assemia and iron deficiency [21]. They are useful when re-
sources are limited. However, none of the differentiation in-
dices or formula provided 100% sensitivity and 100% speci-
ficity for discrimination purposes [21]. Further confirma-
tory tests are needed. Therefore, it is not suitable in Korea to 
screen patients with microcytosis using these formulae. 
Migration of Hb variants is identified on 15 zones of the 
Minicap system. Zone 7 identifies HbF, as well as other Hb 
variants, including Hb Q-Thailand (G-Taichung), Hb Rich-
mond, Hb G-San Jose, Hb Porto Alegre, Hb Presbyterian, 
Hb Alabama, Hb Chapel Hill, Hb Bassett, Hb Barcelona, Hb 
Geldrop Santa Anna, Hb Swan River, Hb Burke, Hb Mani-
toba I, Hb Manitoba II, “J-Paris-I” HbA2 variant, and dena-
tured HbS. Therefore, when HbF levels are elevated, it has 
to be considered that other Hb variants, although scarce, are 
possible. 
Reduced MCV, MCH, and HbA2 might indicate either 
iron deficiency or α-thalassemia [7]. In this study, 29 patients 
had decreased HbA2. Among these, 25 cases were diagnosed 
as IDA, and 4 cases were considered to have the α-thalasse-
mia trait. This condition is benign and most patients are di-
agnosed on routine screening [22]. 
In the present study, one of the donors identified as hav-
ing β-thalassemia was a Southeast Asian from Burma. This 
reflects the growing migration from areas with high preva-
lence of β-thalassemia to Korea and the importance of scre-
ening for pregnant women of those ethnic groups. 
The β-thalassemia gene frequency in Koreans is approxi-
mately 0.1% or less [23]. In this study, the total incidence of 
abnormal hemoglobin fractions was 1.4% as detected by 
both CE and CA, which is slightly higher than the results 
previously reported [16]. We speculate that various factors, 
including the criteria used for selection of study samples, 
screening methods, and epidemiologic characteristics, may 
contribute to the different results of the studies. Screening 
of a larger population is needed to understand more pre-
cisely the incidence of hemoglobinopathies in the Korean 
population.
As the prevalence of hemoglobinopathies is very low in 
Korea, Hb electrophoresis has not been a routine test for 
evaluating anemia patients. However, underestimation of 
thalassemias and hemoglobinopathies may result in misdi-
agnosing anemic patients to IDA, thus causing the patients 
to suffer from prolonged inappropriate treatment. Further-
more, due to increased migration of ethnic minorities with 
high rates of globin gene defects to Korea, the problem of 
thalassemia has to be considered in this country. We sug-
gest CE as a screening tool for hemoglobin disorders in the 
Korean population. CE is comparable to CA in terms of re-
liable measurement of Hb fractions, and is suitable for sim-
ple screening.Kim J-E, et al.  •  Capillary EP for Hemoglobinopathies
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